Search Results

Return to List
Results 1–20 of 22
Title Date
1.

Tubal Ligation with Cesarean Delivery

Number 205

Tubal ligation at the time of cesarean delivery requires significant additional physician work even though the technical work of the procedure is brief. Informed consent by the patient requires considerably more counseling by the physician regarding potential risks and benefits of this procedure t...

August 1998

PDF Format
2.

Breastfeeding: Maternal and Infant Aspects

Number 361

(Reaffirmed 2013)

ABSTRACT: Evidence continues to mount regarding the value of breastfeeding for both women and their infants. The American College of Obstetricians and Gynecologists strongly supports breastfeeding and calls on its Fellows, other health care professionals caring for women and their infants, hospita...

February 2007

PDF Format
3.

Sterilization of Women Including Those With Mental Disabilities

Number 371

(Reaffirmed 2009)

ABSTRACT: Sterilization, like any other surgical procedure, must be carried out under the general ethical principles of respect for autonomy, beneficence, and justice. Women requesting sterilization should be encouraged to discuss their decision and associated issues with their husbands or other a...

July 2007

PDF Format
4.

Brand Versus Generic Oral Contraceptives

Number 375

(Reaffirmed 2013)

ABSTRACT:The U.S. Food and Drug Administration considers generic and brand name oral contraceptive (OC) products clinically equivalent and interchangeable. The American College of Obstetricians and Gynecologists supports patient or clinician requests for branded OCs or continuation of the same gen...

August 2007

PDF Format
5.

The Limits of Conscientious Refusal in Reproductive Medicine

Number 385

(Reaffirmed 2013)

ABSTRACT: Health care providers occasionally may find that providing indicated, even standard, care would present for them a personal moral problem—a conflict of conscience—particularly in the field of reproductive medicine. Although respect for conscience is important, conscientious refusals shou...

November 2007

PDF Format
6.

Misoprostol for Postabortion Care

Number 427

ABSTRACT: The World Health Organization estimates that 67,000 women, mostly in developing countries, die each year from untreated or inadequately treated abortion complications. Postabortion care, a term commonly used by the international reproductive health community, refers to a specific set of ...

February 2009

PDF Format
7.

Induced Abortion and Breast Cancer Risk

Number 434

(Reaffirmed 2013, Replaces No. 285, August 2003)

ABSTRACT: The relationship between induced abortion and the subsequent development of breast cancer has been the subject of a substantial amount of epidemiologic study. Early studies of the relationship between prior induced abortion and breast cancer risk were methodologically flawed. More rigoro...

June 2009

PDF Format
8.

Increasing Use of Contraceptive Implants and Intrauterine Devices To Reduce Unintended Pregnancy

Number 450

(Reaffirmed 2011)

ABSTRACT: High unintended pregnancy rates in the United States may in part be the result of relatively low use of long-acting reversible contraceptive (LARC) methods, specifically the contraceptive implant and intrauterine devices. Top-tier reversible methods share the characteristic of requiring ...

December 2009

PDF Format
9.

Preparing for Disasters: Perspectives on Women

Number 457

(Reaffirmed 2014)

ABSTRACT: Emergency plans that specifically address the needs of women, infants, and children during disasters are currently underdeveloped in the United States. Pregnant women, infants, and children are adversely affected by disasters resulting in an increased number of infants with intrauterine ...

June 2010

PDF Format
10.

Understanding and Using the US Medical Eligibility Criteria for Contraceptive Use, 2010

Number 505

(Reaffirmed 2014)

ABSTRACT: The 2010 U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) issued by the Centers for Disease Control and Prevention gives comprehensive, evidence-based guidance to clinicians providing family planning services to women, especially women with medical conditions. The Ameri...

September 2011

PDF Format
11.

Health Care for Pregnant and Postpartum Incarcerated Women and Adolescent Females

Number 511

(Reaffirmed 2013)

ABSTRACT: Clinicians who provide care for incarcerated women should be aware of the special health care needs of pregnant incarcerated women and the specific issues related to the use of restraints during pregnancy and the postpartum period. The use of restraints on pregnant incarcerated women and...

November 2011

PDF Format
12.

Reproductive Health Care for Incarcerated Women and Adolescent Females

Number 535

ABSTRACT: Increasing numbers of women and adolescent females are incarcerated each year in the United States and they represent an increasing proportion of inmates in the U.S. correctional system. Incarcerated women and adolescent females often come from disadvantaged environments and have high ra...

August 2012

PDF Format
13.

Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices

Number 539

(Replaces No. 392, December 2007, Reaffirmed 2014)

ABSTRACT: Long-acting reversible contraception (LARC)—intrauterine devices and the contraceptive implant—are safe and appropriate contraceptive methods for most women and adolescents. The LARC methods are top-tier contraceptives based on effectiveness, with pregnancy rates of less than 1% per year...

October 2012

PDF Format
14.

Risk of Venous Thromboembolism Among Users of Drospirenone-Containing Oral Contraceptive Pills

Number 540

ABSTRACT: Although the risk of venous thromboembolism is increased among oral contraceptive users compared with nonusers who are not pregnant and not taking hormones, and some data have suggested that use of drospirenone-containing pills has a higher risk of venous thromboembolism, this risk is st...

November 2012

PDF Format
15.

Access to Emergency Contraception

Number 542

ABSTRACT: Emergency contraception includes contraceptive methods used to prevent pregnancy in the first few days after unprotected intercourse, sexual assault, or contraceptive failure. Although the U.S. Food and Drug Administration approved the first dedicated product for emergency contraception ...

November 2012

PDF Format
16.

Over-the-Counter Access to Oral Contraceptives

Number 544

ABSTRACT: Unintended pregnancy remains a major public health problem in the United States. Access and cost issues are common reasons why women either do not use contraception or have gaps in use. A potential way to improve contraceptive access and use, and possibly decrease unintended pregnancy ra...

December 2012

PDF Format
17.

Health Care for Women in the Military and Women Veterans

Number 547

Abstract: Military service is associated with unique risks to women’s reproductive health. As increasing numbers of women are serving in the military, and a greater proportion of United States Veterans are women, it is essential that obstetrician–-gynecologists are aware of and well prepared to ad...

December 2012

PDF Format
18.

Breastfeeding in Underserved Women: Increasing Initiation and Continuation of Breastfeeding

Number 570

ABSTRACT: Maternal and infant benefits from breastfeeding are well documented and are especially important to underserved women. Underserved women are disproportionately likely to experience adverse health outcomes that may improve with breastfeeding. They face unique barriers and have low rates o...

August 2013

PDF Format
19.

Understanding and Using the U.S. Selected Practice Recommendations for Contraceptive Use, 2013

Number 577

ABSTRACT: The U.S. Selected Practice Recommendations for Contraceptive Use, 2013 (U.S. SPR), issued by the Centers for Disease Control and Prevention is a companion piece to the Centers for Disease Control and Prevention’s U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. The U.S. Med...

November 2013

PDF Format
20.

Depot Medroxyprogesterone Acetate and Bone Effects

Number 602

(Replaces Committee Opinion Number 415, September 2008)

ABSTRACT: Depot medroxyprogesterone acetate (DMPA) is a highly effective injectable contraceptive that affords privacy and has a convenient dose schedule of four times per year, making it appealing to many users, especially adolescents. Although the use of DMPA is associated with loss of bone mine...

June 2014

PDF Format